BRCA2 and melanoma: In the same way, analyses of familial melanoma cohorts have reported germline pathogenic alleles of BRCA2 (Gumaste et al., 2015; Tuominen et al., 2016) providing some evidence that germline variants in these genes might contribute to disease pathogenesis—but do they?